These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 14976321

  • 1. Estimating the cost-effectiveness of stroke units in France compared with conventional care.
    Launois R, Giroud M, Mégnigbêto AC, Le Lay K, Présenté G, Mahagne MH, Durand I, Gaudin AF.
    Stroke; 2004 Mar; 35(3):770-5. PubMed ID: 14976321
    [Abstract] [Full Text] [Related]

  • 2. Alternative strategies for stroke care: cost-effectiveness and cost-utility analyses from a prospective randomized controlled trial.
    Patel A, Knapp M, Perez I, Evans A, Kalra L.
    Stroke; 2004 Jan; 35(1):196-203. PubMed ID: 14684783
    [Abstract] [Full Text] [Related]

  • 3. Economic Evaluation of Telemedicine for Patients in ICUs.
    Yoo BK, Kim M, Sasaki T, Melnikow J, Marcin JP.
    Crit Care Med; 2016 Feb; 44(2):265-74. PubMed ID: 26540398
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESIS).
    Dewey HM, Thrift AG, Mihalopoulos C, Carter R, Macdonell RA, McNeil JJ, Donnan GA.
    Stroke; 2001 Oct; 32(10):2409-16. PubMed ID: 11588334
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack.
    Kamel H, Johnston SC, Easton JD, Kim AS.
    Stroke; 2012 Mar; 43(3):881-3. PubMed ID: 22308255
    [Abstract] [Full Text] [Related]

  • 8. Are stroke units cost effective? Evidence from a New Zealand stroke incidence and population-based study.
    Te Ao BJ, Brown PM, Feigin VL, Anderson CS.
    Int J Stroke; 2012 Dec; 7(8):623-30. PubMed ID: 22010968
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Health Economic Evaluation of a Strict Glucose Control Guideline Implemented Using Point-of-Care Testing in Three Intensive Care Units in The Netherlands.
    van Hooijdonk RT, Steuten LM, Kip MM, Monteban H, Mulder MR, van Braam Houckgeest F, van der Sluijs JP, Abu-Hanna A, Spronk PE, Schultz MJ.
    Appl Health Econ Health Policy; 2015 Aug; 13(4):399-407. PubMed ID: 25958191
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
    Berg J, Lindgren P, Spiesser J, Parry D, Jönsson B.
    Clin Ther; 2007 Jun; 29(6):1184-202. PubMed ID: 17692733
    [Abstract] [Full Text] [Related]

  • 12. Economic evaluation of Australian stroke services: a prospective, multicenter study comparing dedicated stroke units with other care modalities.
    Moodie M, Cadilhac D, Pearce D, Mihalopoulos C, Carter R, Davis S, Donnan G, SCOPES Study Group.
    Stroke; 2006 Nov; 37(11):2790-5. PubMed ID: 17008615
    [Abstract] [Full Text] [Related]

  • 13. Economic analysis of decitabine versus best supportive care in the treatment of intermediate- and high-risk myelodysplastic syndromes from a US payer perspective.
    Pan F, Peng S, Fleurence R, Linnehan JE, Knopf K, Kim E.
    Clin Ther; 2010 Dec; 32(14):2444-56. PubMed ID: 21353113
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38.
    Mahoney EM, Wang K, Arnold SV, Proskorovsky I, Wiviott S, Antman E, Braunwald E, Cohen DJ.
    Circulation; 2010 Jan 05; 121(1):71-9. PubMed ID: 20026770
    [Abstract] [Full Text] [Related]

  • 15. Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale.
    Pickett CA, Villines TC, Ferguson MA, Hulten EA.
    Am J Cardiol; 2014 Nov 15; 114(10):1584-9. PubMed ID: 25248812
    [Abstract] [Full Text] [Related]

  • 16. Randomized controlled study of stroke unit care versus stroke team care in different stroke subtypes.
    Evans A, Harraf F, Donaldson N, Kalra L.
    Stroke; 2002 Feb 15; 33(2):449-55. PubMed ID: 11823651
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The potential role of cost-utility analysis in the decision to implement major system change in acute stroke services in metropolitan areas in England.
    Hunter RM, Fulop NJ, Boaden RJ, McKevitt C, Perry C, Ramsay AIG, Rudd AG, Turner SJ, Tyrrell PJ, Wolfe CDA, Morris S.
    Health Res Policy Syst; 2018 Mar 14; 16(1):23. PubMed ID: 29540216
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.